Clinico-epidemiological Aspects of Cutaneous Lesions in Injecting Drug Users Visiting an Oral Substitution Therapy Centre in Northern India: A Cross-Sectional Study

Overview

Journal Dermatol Pract Concept

Specialty Dermatology

Date 2022 Dec 19

PMID 36534568

Authors

Shaminder Singh Dhillon

Tejinder Kaur

Neeru Bala

Mankaranpreet

Affiliations

Soon will be listed here.

Abstract

Introduction: Drug abuse has been taking a great toll on the health and well-being of the community for the past few decades. Substance abuse can lead to several cutaneous manifestations as direct injuries by the offending drug or the practices of drug usage cause secondary damage to the skin. The early recognition of these signs is of utmost importance to prevent long-term complications.

Objectives: To study the clinical-epidemiological profile of the skin diseases in Injecting Drug Users (IDU) attending an Oral Substitution Therapy (OST) Center in Northern India and to assess the psychological impact of skin conditions in IDUs attending OSTs.

Methods: This cross-sectional observational study involved 100 IDUs enrolled from the OST center who were subjected to brief history taking and clinical and dermoscopic evaluation of skin lesions. Dermatological quality of life index (DLQI), Depression, Anxiety, Stress Scale (DASS), and WHO-quality of life (QoL) questionnaire were used to evaluate the impact of skin lesions on psycho-social health and QoL of IDUs.

Results: Cutaneous lesions ranged from track marks to severe ulcerations and scarring. Mucosal lesions also took a toll on several patients. The patients had varying degrees of anxiety, depression, and mental stress.

Conclusions: Injecting Drug Abusers are prone to acquire skin diseases due to injury caused by drugs as well as by drug practices adopted and the degree of neglect may worsen these conditions. These cutaneous lesions hamper QoL and cause psychosocial disturbances.

References

Binswanger I, Kral A, Bluthenthal R, Rybold D, Edlin B . High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis. 2000; 30(3):579-81. DOI: 10.1086/313703. View

Brewer J, Meves A, Bostwick J, Hamacher K, Pittelkow M . Cocaine abuse: dermatologic manifestations and therapeutic approaches. J Am Acad Dermatol. 2008; 59(3):483-7. DOI: 10.1016/j.jaad.2008.03.040. View

Elpern D . Cocaine abuse and delusions of parasitosis. Cutis. 1988; 42(4):273-4. View

Cooper J, Spilke C, Denton M, Jamieson S . Clostridium botulinum: an increasing complication of heroin misuse. Eur J Emerg Med. 2005; 12(5):251-2. DOI: 10.1097/00063110-200510000-00011. View

Pieper B, Kirsner R, Templin T, Birk T . Chronic venous disease and injection drug use. Arch Intern Med. 2007; 167(16):1807. DOI: 10.1001/archinte.167.16.1807-a. View

Somers W, Lowe F . Localized gangrene of the scrotum and penis: a complication of heroin injection into the femoral vessels. J Urol. 1986; 136(1):111-3. DOI: 10.1016/s0022-5347(17)44750-1. View

Pierce M, Hayhurst K, Bird S, Hickman M, Seddon T, Dunn G . Insights into the link between drug use and criminality: Lifetime offending of criminally-active opiate users. Drug Alcohol Depend. 2017; 179:309-316. PMC: 5608072. DOI: 10.1016/j.drugalcdep.2017.07.024. View

Hennings C, Miller J . Illicit drugs: What dermatologists need to know. J Am Acad Dermatol. 2013; 69(1):135-42. DOI: 10.1016/j.jaad.2012.12.968. View

Georgiadis G, Bessias N, Pavlidis P, Pomoni M, Batakis N, Lazarides M . Infected false aneurysms of the limbs secondary to chronic intravenous drug abuse: analysis of perioperative considerations and operative outcomes. Surg Today. 2007; 37(10):837-44. DOI: 10.1007/s00595-006-3495-z. View

10.

Jones A, Warken K, Tyring S . The cutaneous manifestations of viral hepatitis. Dermatol Clin. 2002; 20(2):233-47, vi. DOI: 10.1016/s0733-8635(01)00010-9. View

11.

Kocovski L, Butany J, Nair V . Femoral artery pseudoaneurysm due to Candida albicans in an injection drug user. Cardiovasc Pathol. 2013; 23(1):50-3. DOI: 10.1016/j.carpath.2013.07.003. View

12.

Altman K, Vanness E, Westergaard R . Cutaneous manifestations of human immunodeficiency virus: a clinical update. Curr Infect Dis Rep. 2015; 17(3):464. PMC: 4447481. DOI: 10.1007/s11908-015-0464-y. View

13.

White W, Barrett S . Penile ulcer in heroin abuse: a case report. Cutis. 1982; 29(1):62-3, 69. View

14.

Fox T, Oliver G, Ellis S . The destructive capacity of drug abuse: an overview exploring the harmful potential of drug abuse both to the individual and to society. ISRN Addict. 2015; 2013:450348. PMC: 4392977. DOI: 10.1155/2013/450348. View

15.

Chen S . Dermatology quality of life instruments: sorting out the quagmire. J Invest Dermatol. 2007; 127(12):2695-6. DOI: 10.1038/sj.jid.5701176. View

16.

Smith M, Robinowitz N, Chaulk P, Johnson K . Self-care and risk reduction habits in older injection drug users with chronic wounds: a cross-sectional study. Harm Reduct J. 2014; 11(1):28. PMC: 4213493. DOI: 10.1186/1477-7517-11-28. View

17.

Olopoenia L, Mody V, Reynolds M . Eikenella corrodens endocarditis in an intravenous drug user: case report and literature review. J Natl Med Assoc. 1994; 86(4):313-5. PMC: 2607643. View

18.

Del Giudice P . Cutaneous complications of intravenous drug abuse. Br J Dermatol. 2004; 150(1):1-10. DOI: 10.1111/j.1365-2133.2004.05607.x. View

19.

Khalsa J, Treisman G, McCance-Katz E, Tedaldi E . Medical consequences of drug abuse and co-occurring infections: research at the National Institute on Drug Abuse. Subst Abus. 2008; 29(3):5-16. PMC: 2654580. DOI: 10.1080/08897070802218661. View

20.

Degenhardt L, Peacock A, Colledge S, Leung J, Grebely J, Vickerman P . Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017; 5(12):e1192-e1207. PMC: 5683738. DOI: 10.1016/S2214-109X(17)30375-3. View